Index of reports
> Cases with Concomitant Disease Progression (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ilaris (Canakinumab) where reactions include concomitant disease progression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ilaris side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: male, weighing 113.2 kg (249.0 pounds)
Reactions: Unresponsive To Stimuli, Haemorrhage Intracranial, Cerebral Artery Occlusion, Cerebrovascular Accident, Concomitant Disease Progression, Convulsion, Speech Disorder, Hypoaesthesia Oral, Amyloidosis, Brain Oedema, Respiration Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ilaris
Other drugs received by patient: Keppra
Possible Ilaris side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: male, weighing 116.1 kg (255.4 pounds)
Reactions: Delirium, Concomitant Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: double-blind
Start date: 2011-06-02
Triamcinolone Acetonide
Dosage: double-blind
Indication: Gouty Arthritis
Start date: 2011-06-02
Furosemide
Dosage: 80 mg, qd
Administration route: Oral
Indication: Oedema
Start date: 2010-03-17
Placebo
Dosage: double-blind
Indication: Gouty Arthritis
Start date: 2011-06-02
Ilaris
Dosage: double-blind
Indication: Gouty Arthritis
Start date: 2011-06-02
Blinded NO Treatment Received
Dosage: double-blind
Indication: Gouty Arthritis
Start date: 2011-06-02
Other drugs received by patient: Plavix; Triamcinolone; Metoprolol Tartrate; Tramadol HCL; Januvia; Acarbose; Simvastatin; Colchicine; Cardura; Nitroglycerin; Fexofenadine; Lutein; Catapres-TTS-2; Proscar; Omeprazole
Possible Ilaris side effects in female
Reported by a physician from United States on 2012-05-15
Patient: female, weighing 90.3 kg (198.7 pounds)
Reactions: Overdose, Palpitations, Angina Unstable, Suicide Attempt, Concomitant Disease Progression, Suicidal Ideation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Klonopin
Dosage: weekly
Indication: Anxiety
Start date: 2011-08-18
Metoprolol Succinate Extended Release
Dosage: 50 mg, bid
Administration route: Oral
Start date: 2012-05-01
Placebo
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Metoprolol Succinate Extended Release
Dosage: 25 mg, bid
Administration route: Oral
Start date: 2011-06-17
End date: 2012-04-30
Ilaris
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Other drugs received by patient: Trazodone HCL; Buspar; Aspirin; Trazodone HCL; Effexor; Effexor; Effexor; Effexor; Buspar
Possible Ilaris side effects in male
Reported by a physician from Germany on 2012-05-09
Patient: male, weighing 126.9 kg (279.2 pounds)
Reactions: Gouty Arthritis, Diabetic Foot Infection, Concomitant Disease Progression, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: code not broken
Indication: Arteriosclerosis
Start date: 2011-03-31
Placebo
Dosage: code not broken
Indication: Arteriosclerosis
Start date: 2011-03-31
Other drugs received by patient: Levemir; Cymbalta; Ebrantil; Metoprolol Tartrate; Novorapid; Aspirin; Clopidogrel; Metoprolol Tartrate; Simvastatin; Torsemide; Aprovel
Possible Ilaris side effects in female
Reported by a physician from United States on 2012-05-08
Patient: female, weighing 90.3 kg (198.7 pounds)
Reactions: Overdose, Palpitations, Angina Unstable, Suicide Attempt, Concomitant Disease Progression, Suicidal Ideation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Klonopin
Dosage: weekly
Indication: Anxiety
Start date: 2011-08-18
Placebo
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Ilaris
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Blinded NO Treatment Received
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Metoprolol Succinate Extended Release
Dosage: 25 mg, bid
Administration route: Oral
Start date: 2011-06-17
End date: 2012-04-30
Metoprolol Succinate Extended Release
Dosage: 50 mg, bid
Administration route: Oral
Start date: 2012-05-01
Other drugs received by patient: Buspar; Buspar; Effexor; Effexor; Trazodone HCL; Aspirin; Effexor
Possible Ilaris side effects in female
Reported by a physician from United States on 2012-03-23
Patient: female, weighing 84.6 kg (186.1 pounds)
Reactions: Pneumonia, Haemoptysis, Concomitant Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Placebo
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-09-06
Ilaris
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-09-06
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-09-06
Other drugs received by patient: Lisinopril; Lisinopril; Fenofibrate; Carvedilol; Simvastatin; Aspirin; Plavix; Carvedilol
Possible Ilaris side effects in male
Reported by a physician from Germany on 2012-02-28
Patient: male, weighing 126.9 kg (279.2 pounds)
Reactions: Gouty Arthritis, Diabetic Foot Infection, Concomitant Disease Progression, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: double blinded
Indication: Arteriosclerosis
Start date: 2011-03-31
Blinded Placebo
Dosage: double blinded
Indication: Arteriosclerosis
Start date: 2011-03-31
Other drugs received by patient: Irbesartan; Ebrantil; Metoprolol Tartrate; Novorapid; Torsemide; Simvastatin; Metoprolol Tartrate; Levemir; Aspirin; Clopidogrel; Cymbalta
Possible Ilaris side effects in female
Reported by a physician from United States on 2012-02-24
Patient: female, weighing 84.6 kg (186.1 pounds)
Reactions: Pneumonia, Haemoptysis, Concomitant Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Placebo
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-09-06
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-09-06
Ilaris
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-09-06
Other drugs received by patient: Aspirin; Fenofibrate; Lisinopril; Plavix; Carvedilol; Lisinopril; Simvastatin; Carvedilol
Possible Ilaris side effects in male
Reported by a physician from Italy on 2012-02-17
Patient: male, weighing 77.7 kg (170.9 pounds)
Reactions: Pneumonia, Anaemia, Condition Aggravated, Concomitant Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2012-01-17
Blinded NO Treatment Received
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2012-01-17
Placebo
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2012-01-17
Warfarin
Dosage: unk
Start date: 2011-04-29
Other drugs received by patient: Aspirin; Furosemide; Nitroglycerin; Ramipril
Possible Ilaris side effects in male
Reported by a physician from Germany on 2012-02-03
Patient: male, weighing 126.9 kg (279.2 pounds)
Reactions: Gouty Tophus, Diabetic Foot Infection, Concomitant Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: blinded
Indication: Arteriosclerosis
Start date: 2011-03-31
Placebo
Dosage: blinded
Indication: Arteriosclerosis
Start date: 2011-03-31
Other drugs received by patient: Levemir; Novorapid; Irbesartan; Ebrantil; Metoprolol; Metoprolol; Clopidogrel; Simvastatin; Torsemide; Aspirin; Cymbalta
Possible Ilaris side effects in male
Reported by a physician from United States on 2012-02-03
Patient: male, weighing 108.0 kg (237.6 pounds)
Reactions: Concomitant Disease Progression, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naproxen
Dosage: double blind
Indication: Osteoarthritis
Omeprazole
Dosage: double blind
Indication: Osteoarthritis
Ilaris
Dosage: double blind
Indication: Osteoarthritis
Blinded NO Treatment Received
Dosage: double blind
Indication: Osteoarthritis
Other drugs received by patient: Methotrexate
Possible Ilaris side effects in female
Reported by a physician from United States on 2012-01-20
Patient: female, weighing 90.3 kg (198.7 pounds)
Reactions: Overdose, Suicide Attempt, Concomitant Disease Progression
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Klonopin
Dosage: weekly
Indication: Anxiety
Start date: 2011-08-18
Metoprolol Succinate Extended Release
Ilaris
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Blinded NO Treatment Received
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Blinded Placebo
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Other drugs received by patient: Effexor; Effexor; Effexor
Possible Ilaris side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05
Patient: female, weighing 90.3 kg (198.7 pounds)
Reactions: Overdose, Suicide Attempt, Concomitant Disease Progression
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Blinded NO Treatment Received
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Metoprolol Succinate Extended Release
Placebo
Dosage: double blinded
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-06-23
Klonopin
Dosage: weekly
Indication: Anxiety
Start date: 2011-08-18
Other drugs received by patient: Effexor; Effexor
|